(Q38540095)

3 September 2017

1 reference

title

IgG4-related disease and the kidney (English)

1 reference

3 September 2017

1 reference

retroperitoneal fibrosis

1 reference

Frank B Cortazar

1

1 reference

PubMed ID

26122730

3 September 2017

John H Stone

series ordinal

2

1 reference

PubMed ID

26122730

3 September 2017

language of work or name

English

0 references

publication date

30 June 2015

1 reference

Nature Reviews Nephrology

3 September 2017

1 reference

3 September 2017

11

1 reference

3 September 2017

10

1 reference

3 September 2017

599-609

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2015.95

3 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Consensus statement on the pathology of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Diagnosis of IgG4-related tubulointerstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Spectrum of Disorders Associated with Elevated Serum IgG4 Levels Encountered in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Standard steroid treatment for autoimmune pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

What is IgG4? A review of the biology of a unique immunoglobulin subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Immunoglobulin G4: an odd antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Pathogenesis of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

The changing profile of acute tubulointerstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis: Detailed Analysis of 20 Japanese Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Proposal for diagnostic criteria for IgG4-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

21 January 2018

Retroperitoneal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

The clinical course of patients with IgG4-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Antihypertensive therapy in the presence of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

High serum IgG4 concentrations in patients with sclerosing pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

A new clinicopathological entity of IgG4-related autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

The diagnostic utility of serum IgG4 concentrations in IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Idiopathic hypocomplementemic immune-complex-mediated tubulointerstitial nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Characteristic tubulointerstitial nephritis in IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Membranous glomerulonephritis is a manifestation of IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Pathologic differentiation between lupus and nonlupus membranous glomerulopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Treatment approaches to IgG4-related systemic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.95

31 March 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/26122730

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26122730

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

IgG4 Inflammatory Pseudotumor of the Kidney

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26122730

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2015.95

1 reference

3 September 2017

1 reference

PubMed ID

26122730